In the same vein, Stephen et al. developed iron oxide nanoparticles functionalized with CTX to deliver 6-O-benzylguanine, a O6-methylguanine-DNA methyltransferase inhibitor, to GBM cells (after intratumoral administration in GBM orthotopic model) (66). This evidence concerns the gene MGMT and glioblastoma.